Overview
We leverage cutting-edge molecular technologies to explore tumour biology, treatment resistance, and disease progression.
Combining Scientific Methods in Ovarian Cancer Research
Ovarian cancer is often diagnosed late and has a high relapse rate. By enrolling a Saudi patient cohort and monitoring plasma samples for circulating tumour DNA over a 5-year period, we aim to create customised assays to detect recurrence early, leading to better management and enhanced survival rates.
Our research will also allow the establishment of a Saudi-specific ovarian cancer genomics database, aligning with the Kingdom’s Vision 2030 healthcare goals.
Our Team
Our mission is to bridge scientific discovery and clinical impact.

Abdu Khalid Siraj
Senior Scientist / Team Leader

Eman Abdulqadier Abdulrazaq
Post-Doctoral Fellow

Khadija Abdulrahman Alobaisi
Research Associate
Projects
We advance cancer care through translational research.
Beta Version
Research services